Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Johnson and Johnson
Colorcon
AstraZeneca
Merck

Last Updated: January 27, 2020

DrugPatentWatch Database Preview

EQUIPIN Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Equipin, and what generic alternatives are available?

Equipin is a drug marketed by Mission Pharma and is included in one NDA.

The generic ingredient in EQUIPIN is homatropine methylbromide. There are five drug master file entries for this compound. Additional details are available on the homatropine methylbromide profile page.

Summary for EQUIPIN
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 37
Formulation / Manufacturing:see details
DailyMed Link:EQUIPIN at DailyMed
Drug patent expirations by year for EQUIPIN
Synonyms for EQUIPIN
(1R,3r,5S)-3-(2-hydroxy-2-phenylacetoxy)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide
(1R,3S,5S)-3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-8-azabicyclo[3.2.1]octan-8-ium bromide
(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenyl-acetate bromide
(8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenylacetate bromide
[(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-oxidanyl-2-phenyl-ethanoate bromide
[(5S)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-hydroxy-2-phenylacetate bromide
1786394-41-9
2-hydroxy-2-phenylacetic acid [(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] ester bromide
3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-8-azabicyclo[3.2.1]octan-8-ium bromide
3-[2-hydroxy(phenyl)acetoxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide
3-{[hydroxy(phenyl)acetyl]oxy}-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide
3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate
3alpha-Hydroxy-8-methyl-1alphaH,5alphaH-tropanium bromide mandelate
55198-66-8
58725-74-9
8-Azoniabicyclo(3.2.1)octane, 3-((2-hydroxy-2-phenylacetyl)oxy)-8,8-dimethyl-, bromide (1:1), (3-endo)-
8-Azoniabicyclo(3.2.1)octane, 3-((hydroxyphenylacetyl)oxy)-8,8-dimethyl-, bromide, (3-endo)-
8-Azoniabicyclo(3.2.1)octane, 3-((hydroxyphenylacetyl)oxy)-8,8-dimethyl-, bromide, endo-
8-Azoniabicyclo[3.2.1]octane, 3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-, bromide (1:1), (3-endo)-
8-Methylhomatropinium bromide
8,8-dimethyl-8-azabicyclo[3.2.1]oct-3-yl 2-hydroxy-2-phenylacetate, bromide
80-49-9
A839929
AC1L1MZP
AC1NWAN9
AC1Q1RH8
AK163175
AKOS015896228
AKOS025395549
AN-14686
API0000400
Arkitropin
BCP13099
Benzeneacetic acid, a-hydroxy-,(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
C16H21NO3.CH3Br
Camatropine
CCG-39581
CHEBI:50373
CHEMBL1200851
CS-5716
CTK5F7595
D02070
DB00725
DL-Homatropine methyl bromide
DL-Methylbromide
DTXSID4023127
EINECS 201-284-0
Equipin (TN)
Esopin
H-2560
HMS1920D15
HMS2091J21
HMS3652C19
HMS500G13
Homapin
Homapin-10
Homapin-5
Homatromide
Homatropine (methylbromide)
Homatropine DL- methylbromide
Homatropine methobromide
Homatropine methyl bromide
homatropine methylbromide
Homatropine methylbromide (USP)
Homatropine methylbromide [INN:BAN]
Homatropine methylbromide [USP:INN:BAN]
homatropine methylbromide salt
HOMATROPINEMETHYLBROMIDE
Homatropini methylbromidum
Homatropini methylbromidum [INN-Latin]
HOMATROPINIUM, 8-METHYL-, BROMIDE
Humulon lead salt
HY-B1388
Hycodan, probilagol
I06-2047
KS-00001722
LS-75887
Malcotran
MCULE-4330080118
Mesopin
Methyl Bromide Homatropine
Methylbromure d'homatropine
Methylbromure d'homatropine [INN-French]
Methylhomatropine
Methylhomatropine bromide
Methylhomatropinum bromatum
Metilbromuro de homatropina
Metilbromuro de homatropina [INN-Spanish]
MFCD00050292
MolPort-023-219-684
MolPort-035-758-340
N-methylhomatropine bromide
N-Methylhomatropinium Bromide
NCGC00094694-01
NCGC00094694-02
Novatrin
Novatrine
Novatropine
Npvatropine
NSC 34399
NSC34399
Omatropina metilbromuro
Omatropina metilbromuro [DCIT]
S4024
SCHEMBL77827
Sed-Tems
Sethyl
SPECTRUM1500333
SR-05000002082
SR-05000002082-1
ST24047389
ST50993907
SW219039-1
Tropinium methobromide mandelate

US Patents and Regulatory Information for EQUIPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharma EQUIPIN homatropine methylbromide TABLET, CHEWABLE;ORAL 086310-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Baxter
Johnson and Johnson
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.